Purification and Trypsin Inhibitor Activity of a Sporamin B from Sweet Potato （Ipomoea batatas Lam. 55-2）

Sporamin is a soluble protein in sweet potato, and falls into two distinct homology groups, subfamilies A and B. In this research, a sporamin B was purified and its amino acid sequences, trypsin inhibitor activity （Ti activity） were analyzed. This sporamin B was isolated from sweet potato tubers [Ipomoea batatas （L.） Lam cv. 55-2] through extraction of the water-soluble fraction, dialysis, ultrafiltration and ion-exchange chromatography. Homology determined by polyacrylamide gel electrophoresis showed that mainly one bond appeared in gel after being reduced by SDS （sodium dodecyl sulfate）, or by SDS and 2-mercaptoethanol, or in native situation. By comparing the data of the polypeptide mass Matrix-assisted laser desorption/ionization time-of-flight （MALDI-TOF） mass spectrometry with those of the mass of the theoretical amino acid sequences from NCBI protein database, it was revealed that it was Q40091｜Q40091_IPOBA, sweet potato sporamin B - Ipomoea Batatas （sweet potato） （Batate）. The sequence coverage was 70.6%. N-terminal sequence was SETPV （Ser-Glu-Thr-Pro-Val）. There is a linear relationship between trypsin inhibitor activity （Ti activity） and amounts of this sporamin B （3-18 μg mL-1）. The equation of linear regression was y = 2.5809x ＋ 17.049 （r2 = 0.9966）. There was a curvilinear relationship between Ti activity and amounts of this sporamin B （21-150 μg mL-1）. The equation of curvilinear regression is y = 14.417ln（x） ＋ 23.26 （r2 = 0.9924）. The concentration of sporamin B with Ti activity after heating at 40°C may induce part denature of this sporamin B, and there was no statistic difference after heating at 40, 50, 60°C for 20 min. Heat treatment at more than 90°C leads to a dramatic decrease of trypsin inhibitor efficiency. The results suggested that Q40091｜Q40091_IPOBA was the major sporamin B in sweet potato tubers [Ipomoea Batatas （L.） Lam cv. 55-2], which had strong Ti activity, and was stable to both thermal and DTT （DL-dithiothreitol） relatively.     

蒲公英提取物对LPS诱导小鼠乳腺炎的减轻效应及其机制分析

旨在研究蒲公英提取物对内毒素（LPS）诱导小鼠乳腺炎的减轻效应及其机制分析。将小鼠随机分为空白组、模型组、阳性组和蒲公英提取物高、中、低剂量组。蒲公英提取物高、中、低剂量组分别按10.0、5.0、2.5 g·kg^-1灌胃给药,连续灌胃6 d,2次·d^-1,空白组灌胃等体积生理盐水。末次给药1 h后,于小鼠乳房基部分别灌注50 μL 0.2 mg·mL^-1 LPS,建立LPS诱导的小鼠乳腺炎模型,阳性组在建模后6和12 h腹腔注射5 mg·kg^-1地塞米松。24 h后取血,分离血清,剥离乳腺组织。ELISA法测定小鼠血清肿瘤坏死因子α（TNF-α）、白细胞介素-1β（IL-1β）和白细胞介素-6（IL-6）的含量,髓过氧化物酶（MPO）试剂盒测定小鼠血清MPO的含量,HE染色观察病理变化,Western blot法测定小鼠乳腺中TLR4蛋白以及NF-κB信号通路和MAPKs信号通路相关蛋白的表达。结果显示,蒲公英提取物高、中剂量组对LPS诱导的乳腺炎小鼠血清中TNF-α、IL-1β和IL-6的分泌有极显著抑制作用（P<0.01）,极显著降低小鼠血清中MPO的含量（P<0.01）;蒲公英提取物高、中剂量组能改善LPS诱导的小鼠乳腺组织的病理变化,极显著下调LPS诱导的小鼠乳腺中TLR4、p-IκB、p-p65、p-p38、p-JNK、p-ERK蛋白的表达（P<0.01）。结果表明,蒲公英提取物通过调控NF-κB和MAPKs信号通路对LPS诱导的小鼠乳腺炎有明显减轻作用,为蒲公英的临床开发及应用奠定了基础。     

食用笋周年供应配置技术研究

根据每个竹种的不同的出笋期选用雷竹、角竹、金竹、绿竹、吊丝单及毛竹(冬笋)配置成周年供笋生产模式样板20公顷。对竹笋的产量、笋期,作了观察、调查。认为在年平均气温18℃左右、一月份平均气温7～8℃、极端最低气温不低于-5℃的条件下,或有丛生的食用竹笋生产的地区,可按此模式配置成周年供笋生产。     

拟松材线虫研究进展

松材线虫和拟松材线虫共同构成松材线虫复合群体,为松材线虫病的病原物。拟松材线虫危害过去没有引起足够重视,相关研究工作不如松材线虫细致。近年来,随着拟松材线虫致病性增强现象不断被报道,人们逐步加强了拟松材线虫研究。本文从拟松材线虫分类学特征、致病性研究及与松材线虫关系等角度对拟松材线虫研究进展进行综述,并展望未来可能的研究热点。     

飞机喷洒阿维灭幼脲防治马尾松毛虫试验

2004年6～7月,运用Y-5B型飞机超低量喷洒25%阿维灭幼脲新型生物复合剂防治闽北林区马尾松毛虫中、重度危害面积1 96万hm2。结果表明,25%阿维灭幼脲是一种高效、稳定、安全、持效期长的生物农药,使用525g·hm-2浓度,飞机防治作业20d后,效果可达90%以上,防治效果好。     

常山胡柚叶片DNA的抽提与分析

经反复实验，采用在抽提前加入一定量的抗氧化剂β－巯基乙醇，用冰冻的异丙醇来沉淀DNA，并增加氯仿／异戊醇抽提次数的所谓改良CTAB法，对常山胡柚叶片DNA抽提与分析，不仅成功提取到常山胡柚叶片DNA，而且所得的DNA浓度高、纯度好，20个试样的DNA苹均质量浓度为272.86μg/mL，平均每克鲜叶片可获DNA约82μg，纯度基本上都在1.4-1.8范围内，并经RAPD反应验证，完全能满足常规分子生物学分析的要求。     

利用地径建立林木材积估测模型的探讨

通过实测铁杉、红桦和湖北花楸的地径、胸径、树高和材积，我们建立了根据林木地径估测树木材积的数学模型，具有较高的相关系数，可以应用于森林资源管理和森林生态系统研究。     

Characterization of an intravenous lipopolysaccharide inflammation model in calves with respect to the acute-phase response

Our objective was to develop a lipopolysaccharide (LPS) inflammation model in calves to evaluate the acute-phase response with respect to the release of pro-inflammatory cytokines and acute-phase proteins, fever development and sickness behaviour. Fourteen 4-week-old male Holstein Friesian calves were included and randomly assigned to a negative control group (n = 3) and an LPS-challenged group (n = 11). The latter received an intravenous bolus injection of 0.5 μg of LPS/kg body weight. Blood collection and clinical scoring were performed at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 18, 24, 28, 32, 48, 54 and 72 h post LPS administration (p.a.). In the LPS group, the following clinical signs were observed successively: tachypnoea (on average 18 min p.a.), decubitus (29 min p.a.), general depression (1.75 h p.a.), fever (5 h p.a.) and tachycardia (5 h p.a.). Subsequent to the recovery from respiratory distress, general depression was prominent, which deteriorated when fever increased. One animal did not survive LPS administration, whereas the other animals recovered on average within 6.1 h p.a. Moreover, the challenge significantly increased plasma concentrations of tumour necrosis factor-α, interleukin 6, serum amyloid A and haptoglobin, with peaking levels at 1, 3.5, 24 and 18 h p.a., respectively. The present LPS model was practical and reproducible, caused obvious clinical signs related to endotoxemia and a marked change in the studied inflammatory mediators, making it a suitable model to study the immunomodulatory properties of drugs in future research.     

Propofol attenuates LPS-induced tumor necrosis factor-α, interleukin-6 and nitric oxide expression in canine peripheral blood mononuclear cells possibly through down-regulation of nuclear factor (NF)-κB activation

Sepsis is a major cause of mortality in intensive care medicine. Propofol, an intravenous general anesthetic, has been suggested to have anti-inflammatory properties and able to prevent sepsis induced by Gram-positive and Gram-negative bacteria by down-regulating the gene expression of pro-inflammatory cytokines. However, propofol’s anti-inflammatory effects upon canine peripheral blood mononuclear cells (PBMCs) have not yet been clarified. Here, we isolate canine PBMCs and investigate the effects of propofol on the gene expressions of both lipopolysaccharide (LPS)-induced interleukin-6 (IL-6) and tumor necrosis factor (TNF)-α and upon the production of nitric oxide (NO). Through real-time quantitative PCR and the Griess reagent system, we found that non-cytotoxic levels of propofol significantly inhibited the release of NO and IL-6 and TNF-α gene expression in LPS-induced canine PBMCs. Western blotting revealed that LPS does significantly increase the expression of inducible NO synthase (iNOS) protein in canine PBMCs, while pretreatment with propofol significantly decreases the LPS-induced iNOS protein expression. Propofol, at concentration of 25 µM and 50 µM, also significantly inhibited the LPS-induced nuclear translocation of nuclear factor (NF)-κB p65 protein in canine PBMCs. This diminished TNF-α, IL-6 and iNOS expression, and NO production was in parallel to the respective decreased NF-κB p65 protein nuclear translocation in the LPS-activated canine PBMCs pretreated with 25 µM and 50 µM propofol. This suggests that non-cytotoxic levels of propofol pretreatment can down-regulate LPS-induced inflammatory responses in canine PBMCs, possibly by inhibiting the nuclear translocation of the NF-κB p65 protein.